Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Srivichaivejvivat PCLBKK:VIH-R 79 Cash-to-Debt is 22.00 as of Mar. 2026, which is 3760% above its 10-year median of 0.57. GuruFocus rates BKK:VIH-R with a GF Score™ of 79/100 and a GF Value™ of ฿8.89. The stock has 4 warning signs investors should review. Among 669 Healthcare Providers & Services companies, Srivichaivejvivat PCL ranks better than 84.16% on this metric.
Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Srivichaivejvivat PCL's cash to debt ratio for the quarter that ended in Mar. 2026 was 22.00.
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Srivichaivejvivat PCLcould pay off its debt using the cash in hand for the quarter that ended in Mar. 2026.
The historical rank and industry rank for Srivichaivejvivat PCL's Cash-to-Debt or its related term are showing as below:
BKK:VIH-R'
s Cash-to-Debt Range Over the Past 10 Years
Min: 0.19 Med: 0.57 Max: 22
Current: 22
During the past 13 years, Srivichaivejvivat PCL's highest Cash to Debt Ratio was 22.00. The lowest was 0.19. And the median was 0.57.
BKK:VIH-R's Cash-to-Debt is ranked better than 84.16% of 669
companies
in the Healthcare Providers & Services industry
Industry Median: 0.78
vs BKK:VIH-R: 22.00
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.
Srivichaivejvivat PCL Cash-to-Debt Related Terms
Srivichaivejvivat PCL Cash-to-Debt Historical Data
* Premium members only.
The historical data trend for Srivichaivejvivat PCL's Cash-to-Debt can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
BKK:VIH-R vs HCA, THC, DVA: Cash-to-Debt Comparison
For the Medical Care Facilities subindustry, Srivichaivejvivat PCL's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Srivichaivejvivat PCL Cash-to-Debt vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Srivichaivejvivat PCL's Cash-to-Debt distribution charts can be found below:
* The bar in red indicates where Srivichaivejvivat PCL's Cash-to-Debt falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Srivichaivejvivat PCL (BKK:VIH-R) has a Cash-to-Debt of 22.00 as of Mar. 2026. This is 3760% above median its historical median of 0.57. Over the past decade, Srivichaivejvivat PCL's Cash-to-Debt has ranged from 0.19 to 22.00. According to the industry distribution chart, Srivichaivejvivat PCL ranks #106 out of 669 companies in the Healthcare Providers & Services industry, placing it in the top 15.8%.
Is Srivichaivejvivat PCL's Cash-to-Debt too high?
Srivichaivejvivat PCL's current Cash-to-Debt of 22.00 is 3760% above median its 10-year median of 0.57. Over the past 10 years, this metric has ranged from a low of 0.19 to a high of 22.00. The Healthcare Providers & Services industry median Cash-to-Debt is 0.78. Srivichaivejvivat PCL's value of 22.00 is 2720.5% above this industry median. Based on the distribution chart, Srivichaivejvivat PCL ranks #106 out of 669 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Srivichaivejvivat PCL has a GF Score™ of 79/100, reflecting its overall financial health beyond just this single metric.
How does Srivichaivejvivat PCL's Cash-to-Debt compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Srivichaivejvivat PCL ranks #106 out of 669 companies for Cash-to-Debt. This places Srivichaivejvivat PCL in the top 16% of its industry — outperforming the majority of peers. The industry median Cash-to-Debt is 0.78. Srivichaivejvivat PCL's value of 22.00 is 2720.5% above this benchmark. Historically, Srivichaivejvivat PCL's own Cash-to-Debt has ranged from 0.19 to 22.00 over the past decade. While the company's 10-year median is 0.57 vs. the industry median of 0.78, Srivichaivejvivat PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash-to-Debt for a Healthcare Providers & Services company?
The median Cash-to-Debt among Healthcare Providers & Services companies is 0.78, based on 669 companies in the industry. Companies in the top quartile (top 25%) have a Cash-to-Debt significantly above this median, while those in the bottom quartile fall well below. However, Cash-to-Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Srivichaivejvivat PCL's current Cash-to-Debt of 22.00 is 2720.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash-to-Debt mean?
A high Cash-to-Debt can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median Cash-to-Debt is 0.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Srivichaivejvivat PCL's current Cash-to-Debt is 22.00, which is 3760% above median its own 10-year median of 0.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Srivichaivejvivat PCL stock overvalued right now?
Srivichaivejvivat PCL (BKK:VIH-R) has a current Cash-to-Debt of 22.00. The stock's GF Value™ is ฿8.89, compared to a current price of ฿8.95 — trading 0.7% above its estimated fair value. The current Cash-to-Debt is 22.00, which is 3760% above median its 10-year median of 0.57 and 2720.5% above the Healthcare Providers & Services industry median of 0.78. Srivichaivejvivat PCL's overall GF Score™ is 79/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash-to-Debt calculated?
Cash-to-Debt is calculated from a company's financial statements. For Srivichaivejvivat PCL (BKK:VIH-R), the current Cash-to-Debt is 22.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Srivichaivejvivat PCL (BKK:VIH-R) Overvalued in 2026?
Based on GuruFocus' analysis, Srivichaivejvivat PCL stock appears to be overvalued.
The current stock price of ฿8.95 is trading 0.7% above its estimated GF Value™ of ฿8.89.
Key valuation signals for BKK:VIH-R:
Cash-to-Debt: 22.00 (3760% above median its 10-year median of 0.57)
GF Value™: ฿8.89 vs. price of ฿8.95 (0.7% above fair value)
Industry Position: 2720.5% above the Healthcare Providers & Services median (#106 of 669)
No single metric tells the full story. See the BKK:VIH-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Srivichaivejvivat PCL is engaged in hospital business. The company provides 24-hour medical treatment by specialized doctors, with services in the outpatient department (OPD) by specialized doctors until midnight. Specialized clinics are available, such as comprehensive laparoscopic surgery, orthopedic surgery, urology, vascular surgery, cardiology, nephrology and hemodialysis center, endocrinology, neurology, gastroenterology, pediatric clinic, obstetrics and gynecology clinic, emergency accident center, dental center, health check-up center, Thai Filos Anti-Aging Center. It operates in single segment of hospital business in Thailand only.
79GF Score
Get the complete analysis for BKK:VIH-R
Cash-to-Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:VIH-R has been successfully added to your 
